These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 3905702)

  • 1. Effects of chloroquine on the serum complement system.
    Chakrabarty AK; Saha K; Chopra S; Sen P
    Immunopharmacology; 1985 Oct; 10(2):111-8. PubMed ID: 3905702
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In vitro inhibition of the activation of the human complement and coagulation systems by chloroquine.
    Ramanathan VD; Sengupta U
    Int J Immunopharmacol; 1985; 7(5):769-73. PubMed ID: 4044101
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Complement changes in falciparum malaria infection.
    Phanuphak P; Hanvanich M; Sakulramrung R; Moollaor P; Sitprija V; Phanthumkosol D
    Clin Exp Immunol; 1985 Mar; 59(3):571-6. PubMed ID: 3886219
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Binding of properdin to solid-phase immune complexes: critical role of the classical activation pathway of complement.
    Junker A; Baatrup G; Svehag SE; Wang P; Holmström E; Sturfelt G; Sjöholm AG
    Scand J Immunol; 1998 May; 47(5):481-6. PubMed ID: 9627133
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Assembly of the membrane attack complex promotes decay of the alternative pathway C3 convertase on Neisseria gonorrhoeae.
    Densen P; McRill CM; Ross SC
    J Immunol; 1988 Dec; 141(11):3902-9. PubMed ID: 3141507
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Development and application of an enzyme-linked immunosorbent assay for the quantitation of alternative complement pathway activation in human serum.
    Mayes JT; Schreiber RD; Cooper NR
    J Clin Invest; 1984 Jan; 73(1):160-70. PubMed ID: 6418767
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Anti-leprosy drugs inhibit the complement-mediated solubilization of pre-formed immune complexes in vitro.
    Kashyap A; Sehgal VN; Sahu A; Saha K
    Int J Immunopharmacol; 1992 Feb; 14(2):269-73. PubMed ID: 1624226
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibition of immune precipitation by complement.
    Hong K; Takata Y; Sayama K; Kozono H; Takeda J; Nakano Y; Kinoshita T; Inoue K
    J Immunol; 1984 Sep; 133(3):1464-70. PubMed ID: 6747294
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Requirements for the solubilization of immune aggregates by complement: assembly of a factor B-dependent C3-convertase on the immune complexes.
    Takahashi M; Tack BF; Nussenzweig V
    J Exp Med; 1977 Jan; 145(1):86-100. PubMed ID: 830792
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Demonstration of soluble parasite antigens, the corresponding antibodies and immune complexes in acute malaria].
    Perrin LH; Mackey L; Aguado T; Lambert PH; Miescher PA
    Schweiz Med Wochenschr; 1979 Dec; 109(46):1832-4. PubMed ID: 390695
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Complement fixation by solid phase immune complexes. Reduced capacity in SLE sera.
    Baatrup G; Jonsson H; Sjöholm A; Sturfelt G; Svehag SE
    J Clin Lab Immunol; 1988 Jun; 26(2):73-9. PubMed ID: 3264027
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Human erythrocytes inhibit complement-mediated solubilization of immune complexes.
    Dorval BL; Cosio FG; Birmingham DJ; Hebert LA
    J Immunol; 1989 Apr; 142(8):2721-7. PubMed ID: 2522967
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Complement-mediated defect in clearance and sequestration of sensitized, autologous erythrocytes in rodent malaria.
    Pappas MG; Nussenzweig RS; Nussenzweig V; Shear HL
    J Clin Invest; 1981 Jan; 67(1):183-92. PubMed ID: 7005263
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [In vitro susceptibility of P. falciparum isolates from Abidjan (Côte d'Ivoire) to quinine, artesunate and chloroquine].
    Touré AO; Koné LP; Jambou R; Konan TD; Demba S; Beugre GE; Koné M
    Sante; 2008; 18(1):43-7. PubMed ID: 18684691
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effect of short-term malaria chemoprophylaxis on the immune response of semi-immune adult volunteers.
    Lege-Oguntoye L; Onyemelukwe GC; Maiha BB; Udezue EO; Eckerbom S
    East Afr Med J; 1990 Nov; 67(11):770-8. PubMed ID: 2076677
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Photodynamic action of uroporphyrin on the complement system in porphyria cutanea tarda.
    Meurer M; Schulte C; Weiler A; Goerz G
    Arch Dermatol Res; 1985; 277(4):293-8. PubMed ID: 3923948
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Arthritis associated with chronic active hepatitis: complement activation and characterization of circulating immune complexes.
    Wands JR; Alpert E; Isselbacher KJ
    Gastroenterology; 1975 Dec; 69(6):1286-91. PubMed ID: 1193327
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of chloroquine treatment on complement levels in Plasmodium knowlesi infected Rhesus monkeys.
    Prasad RN; Ganguly NK; Mahajan RC; Garg SK
    Indian J Malariol; 1984 Jun; 21(1):17-20. PubMed ID: 6336062
    [No Abstract]   [Full Text] [Related]  

  • 19. The activation mechanism of human complement system by immune precipitate formed with rabbit IgG antibody.
    Fujita T
    Microbiol Immunol; 1979; 23(10):1023-31. PubMed ID: 514094
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Complement breakdown products in plasma from patients with systemic lupus erythematosus and patients with membranoproliferative or other glomerulonephritis.
    Perrin LH; Lambert PH; Miescher PA
    J Clin Invest; 1975 Jul; 56(1):165-76. PubMed ID: 1141431
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.